Dolphin Medical Services Ltd.
Snapshot View

1.93 ▼0%

08 August 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.dolphinmedicalindia.com
Market Cap 2.91 Cr.
Enterprise Value(EV) 3.59 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -0.12 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 46.92 Trailing Twelve Months Ending 2022-03
Book Value / Share 6.82 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.28 Calculated using Price: 1.93
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.51 Cr. 15,099,952 Shares
FaceValue 10
Company Profile
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
+4.89%
1 Month
+20.62%
3 Month
-4.93%
6 Month
-29.82%
1 Year
-36.93%
2 Year
+36.88%
5 Year
+51.97%
10 Year
+15.57%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -12.99 -6.26 -4.39 -0.36 -2.12 -2.41 -8.60 -3.50 -2.93
Return on Capital Employed (%) -5.35 -3.68 -2.56 -0.06 -1.43 -1.57 -5.38 -2.07 -2.01
Return on Assets (%) -8.26 -3.80 -2.62 -0.21 -1.25 -1.41 -5.15 -2.15 -2.07

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 14 13 13 13 12 12 11 11 10 10
Non Curr. Liab. 9 9 9 9 9 9 7 7 1 1
Curr. Liab. 0 0 0 0 0 0 0 0 1 1
Minority Int.
Equity & Liab. 23 22 22 22 21 21 18 18 12 12
Non Curr. Assets 21 21 20 20 19 19 16 16 10 10
Curr. Assets 2 2 2 2 2 2 2 2 2 2
Misc. Exp. not W/O
Total Assets 23 22 22 22 21 21 18 18 12 12

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 1 1 0 1 0 0 0 0 0 1
Other Income 0 0 0 0 0 0 6 0
Total Income 1 1 0 1 0 0 0 0 6 1
Total Expenditure -2 -1 0 0 0 0 -1 -1 -6 -1
PBIDT -1 0 0 0 0 0 -1 0 0 0
Interest -1 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT -2 -1 -1 0 0 0 -1 0 0 0
Adjusted EPS -1 -1 0 0 0 0 -1 0 0 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 0 0 0 0 0 0
Cash Fr. Inv. -1 0 0 0 0 2 0
Cash Fr. Finan. -1 0 0 0 0 0 -2 0 0
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44 26.44
Public 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56 73.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Unaudited Financial Results For The Quarter Ended 30.06.2022
Unaudited Financial Results for the Quarter ended 30.06.2022
Fri, 05 Aug 2022
Board Meeting Intimation for For Unaudited Results For The Quarter Ended 30.06.2022
DOLPHIN MEDICAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Unaudited Results for the Quarter ended 30.06.2022
Wed, 06 Jul 2022
Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- DR MOHAN PRASAD GV
Designation :- Managing Director / Whole Time Director

Technical Scans View Details >>

Mon, 08 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Dolphin Medical Services Ltd.

Can I Buy Dolphin Medical Serv Shares now?

What is the Share Price of Dolphin Medical Serv?

What is the Relative Strength Index (RSI) Value of Dolphin Medical Serv?

What is the Market Capital (MCAP) of Dolphin Medical Serv?

What are the key metrics to analyse Dolphin Medical Serv?